NEW YORK, May 21, 2026 /PRNewswire/ -- WhiteFiber, Inc. (Nasdaq: WYFI) ("WhiteFiber" or the "Company"), a leading provider of AI infrastructure and high-performance computing solutions, today announced that it has entered into a five-year agreement to provide AI compute infrastructure for an investment-grade technology customer. The deployment will be located in the Paris region and will utilize advanced NVIDIA GPU systems. WhiteFiber (PRNewsfoto/WhiteFiber, Inc.) The agreement represents total contract value in excess of $160 million over the five-year term and is expected to commence service in July 2026, subject to final equipment delivery and acceptance milestones. In connection with the deployment, WhiteFiber has entered into a binding term sheet for project-level financing, which is expected to close in June 2026. The project is expected to be supported by customer prepayments, including 12 months of advance service fees, and project-level financing, with limited long-term reliance on WhiteFiber's corporate balance sheet and existing cash resources. "We continue to see strong demand for AI compute infrastructure from enterprise customers globally," said Sam Tabar, Chief Executive Officer of WhiteFiber. "This agreement reflects our ability to originate large-scale AI compute deployments with long-duration, investment-grade customer commitments and capital-efficient financing structures. It also expands our cloud footprint into Europe and reinforces that demand for high-performance AI infrastructure is global." WhiteFiber has secured third-party data center capacity in France to support the deployment. About WhiteFiber, Inc. WhiteFiber is a provider of artificial intelligence ("AI") infrastructure solutions. WhiteFiber owns high-performance computing data centers and provides cloud services to customers. Our vertically integrated model combines specialized colocation, hosting, and cloud services engineered to maximize performance, efficiency, and margin for gene...

GLP-1s are some of the most popular prescription medications today. Unfortunately, when it comes to them, many Americans still have to choose between their health and their pocketbooks. This includes Medicare beneficiaries, who currently only have their GLP-1s covered if they use the medications to treat an underlying condition, like type 2 diabetes. All that seemed about to change a few months ago, when the government promised a new program -- the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) model -- that would cover GLP-1s for weight loss for Medicare beneficiaries. However, it's been tabled indefinitely. The BALANCE model was originally scheduled to take effect in January 2027 and would have allowed Medicare Part D sponsors to decide whether to cover GLP-1s for weight loss. However, that plan has been delayed, with no indication of when it will now take effect. That doesn't mean Medicare beneficiaries are out of luck, though. There's a new Medicare GLP-1 Bridge program that will take effect in July 2026. This will enable Medicare beneficiaries to have their GLP-1s for weight loss covered by Medicare, as long as their healthcare provider submits a prior authorization request and a prescription for a covered medication. This program was initially only supposed to last through the end of the year, but the government has now extended it through 2027. It's unclear what will happen to it beyond this point. It's also worth noting that, as the GLP-1 Bridge program operates outside of Medicare Part D plans, any money spent on these medications for weight loss won't count toward your Medicare Part D deductible or out-of-pocket maximum. This could increase your retirement healthcare costs this year. If you have any questions about this coverage, contact the Centers for Medicare & Medicaid Services for more information.

US Deploys Aircraft Carrier To Caribbean As Trump Admin Pressures Cuba Authored by Jack Phillips via The Epoch Times (emphasis ours), The U.S. military command operating in the Western Hemisphere said on May 20 that an aircraft carrier strike group entered the Caribbean Sea, as the Trump administration heaps pressure on the Cuban communist regime. In a post on X, U.S. Southern Command said that the USS Nimitz is now in the Caribbean and released video footage of the carrier group. Southern Command did not provide more details about why the carrier group traveled to the region. The Nimitz, it said, "has proven its combat prowess across the globe, ensuring stability and defending democracy from the Taiwan Strait to the Arabian Gulf." The Nimitz, commissioned in 1975, carried out joint naval exercises with the Brazilian Navy off the coast of Rio de Janeiro last week, the U.S. Embassy in Brazil said in a May 14 statement. On May 20, the Department of Justice (DOJ) unsealed a criminal indictment against former Cuban leader Raul Castro, and U.S. Secretary of State Marco Rubio released a video in Spanish urging Cubans to reject the country's communist leadership. According to the DOJ indictment, Castro was indicted in connection with the 1996 downing of civilian planes operated by Miami-based exiles. Castro, now 94, was Cuba's defense minister when the planes were shot down, killing four people. The charges against Castro, the brother of former Cuban leader Fidel Castro, drew pushback from the country's current leader, Miguel Diaz-Canel, in a post on X. " This is a political maneuver, devoid of any legal foundation, aimed solely at padding the fabricated dossier they use to justify the folly of a military aggression against Cuba ," Diaz-Canel wrote. This year, U.S. President Donald Trump has been ratcheting up talk of regime change in Cuba and said he would potentially initiate a "friendly takeover" of the country if its leadership did not open up its economy to American i...

Retirees who want a monthly income without the wild ride of high-yield specialty funds often land on the Amplify CWP Enhanced Dividend Income ETF (NYSEARCA:DIVO). The pitch is straightforward: pair roughly 25 to 30 quality dividend stocks with a tactical covered call overlay that adds option premium on top of regular payouts. DIVO has raised ... DIVO’s 5% Yield Is Impressive, But Its Tactical Covered Call Strategy Costs You 30% of Big Up Months

Mike Coppola/Getty Images Entertainment A JPMorgan Chase & Co.-led bank group boosted a leveraged loan offering for Warner Bros. Discovery ( WBD ) to $10.2B as the media company tries to refinance short-term debt ahead of its planned sale to Paramount Skydance ( PSKY ). The offering is made up of two tranches: a US dollar facility that was raised to $9B from $5B, and a €1 billion ($1.16 billion) portion that’s unchanged, according to a Bloomberg report on Thursday, which cited a person familiar with the matter. The proposed funding comes ahead of Paramount Skydance's $110B purchase of Warner Bros. ( WBD ). The financing is being used to partially pay down a ~$15B bridge facility, according to the report. JPMorgan and Warner Bros. declined to comment. Bloomberg reported on Monday that bankers were preparing to sell $49B of debt for combination of two of Hollywood's biggest legacy media firms. A premarketing process for the debt is expected to start in the next couple of weeks. More on Warner Bros. Discovery, Paramount Skydance Corporation Netflix, Disney, FuboTV, WBD And The Streaming Media Landscape Paramount Skydance Corporation (PSKY) Presents at MoffettNathanson's Media, Internet & Communications Conference Transcript Warner Bros. Discovery: Actually Soft, Not Strong, Earnings; But The Merger Would Cure All, Will It Close? Senators want FCC review of foreign ownership in Warner/Paramount deal Paramount Skydance aims to close Warner Bros. deal in July - report

David McNew/Getty Images News Exxon Mobil ( XOM ) is in talks to acquire rights to produce oil in Venezuela nearly 20 years after it was effectively expelled from the country, in what would be a victory for President Trump, who has sought to open the country's vast natural wealth to U.S. businesses, The New York Times reported Thursday. The deal, which could be finalized and announced as soon as this month, would involve Exxon ( XOM ) signing contracts to produce oil in as many as six fields in several regions in Venezuela, according to the report . Venezuela's government under Hugo Chavez nationalized oil projects owned by Exxon ( XOM ) and other foreign oil companies in 2007, but breaking with most of its peers, Exxon ( XOM ) refused to negotiate, left the country, and began a protracted legal battle in international courts; Venezuela’s government still owes Exxon ~$1B in damages awarded in those cases. Exxon's ( XOM ) dominant economic role in neighboring Guyana was often criticized by Nicolas Maduro, Chavez's successor, who accused the company of sponsoring a hostile government. During a high-profile meeting of oil executives on January 9, six days after Maduro was removed, Exxon ( XOM ) CEO Darren Woods told President Trump that Venezuela was " uninvestable ... We've had our assets seized there twice, and so you can imagine to re-enter a third time would require some pretty significant changes." More on Exxon Mobil Exxon Mobil: Overvalued Despite Impressive Assets Exxon Mobil Sees The Silver Lining In The Global Oil Disruption Exxon Mobil: A Rising Oil Bet

Estee Lauder and Puig end talks over possible merger Reuters

Source: Bloomberg, 5:35

Omega Healthcare ( OHI ) announced on Thursday that President Matthew Gourmand had been named CEO, effective October 1, 2026, succeeding retiring CEO Taylor Pickett. The company also announced the appointment of CAO Neal Ballew as CFO, effective August 1, 2026, following the planned retirement of Bob Stephenson from the role. Gourmand brings eight years of experience at Omega, serving in various leadership roles and bringing in-depth investing experience to the position. Pickett’s retirement would conclude a 25-year tenure as CEO, during which the company delivered over 10,000% shareholder returns and expanded its market value to more than $15B from about $60M. Shares -1.49%. More on Omega Healthcare Investors Omega Healthcare Investors, Inc. (OHI) Q1 2026 Earnings Call Transcript Omega Healthcare Investors: A High-Yield Play On The Silver Tsunami With RIDEA Upside Omega projects $3.19-$3.25 2026 adjusted AFFO per share amid $480M CommuniCare asset sale and RIDEA expansion Omega Healthcare stock down despite beat-and-raise Q1 as tenant health concerns linger Seeking Alpha’s Quant Rating on Omega Healthcare Investors

US equity indexes were off session highs as President Donald Trump appeared open to giving Iran time Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles.

STXCA240EURINSURGR (S24C85GR.Z) 最新股票消息和頭條新聞 Yahoo 財經

Micron Stock Climbs as Samsung Averts Strike and Memory Chip Demand Explodes TipRanks

Cohen & Steers ( CNS ) announced on Thursday that Amit Muni will join the company as EVP and CFO from June 8, 2026. He will oversee finance operations, financial strategy, and investor relations. Amit Muni will replace Michael Donohue, who has been serving as interim CFO since October 2025. Donohue will continue as interim CFO until June 8 and later return to his role as controller. Source: Press Release More on Cohen & Steers Cohen & Steers: Q1 Resilience Holds Fort For Q2 Recovery Cohen & Steers: A Beneficiary Of Challenges In Private Markets Cohen & Steers, Inc. 2026 Q1 - Results - Earnings Call Presentation Cohen & Steers, J.P. Morgan team up on global wealth product distribution Cohen & Steers expects 40% compensation ratio and mid-single-digit G&A growth for 2026 amid ETF expansion

Daniel Hull/iStock Editorial via Getty Images SpaceX Is Growing Quickly, But Operating Losses Are Accelerating Space Exploration Technologies Corp. ( SPCX ) has filed to raise growth capital in an IPO of its Class A common stock, per an S-1 registration statement . SpaceX provides space launch, telecommunications connectivity, and AI-related services globally. The company is growing revenue, but free cash flow is heavily negative due to high capex costs for the AI segment. Success in its orbital AI data center concept relies on a reliable Starship lift capacity, which has yet to be demonstrated, so there are numerous major risks in the near term. What Does SpaceX Do? SpaceX was founded in 2002 by Chairman, CEO and Chief Technical Officer Mr. Elon Musk to first develop rocket-based reusable space launch technologies. In 2019, the company began to deploy low-Earth-orbit broadband satellites to offer internet connectivity options for consumers, commercial customers, and governments in numerous coverage zones worldwide. Earlier in 2026, SpaceX merged with Mr. Musk’s AI development entity, xAI, for its generative AI solutions and infrastructure capabilities. The result has been to combine a company with reliable and lower-cost space lift capacity with a satellite-based broadband service and, potentially in the future, AI infrastructure offering data center capacity in Earth orbit. A breakdown of the company's revenue contribution percentages by segment and type is shown in the pie charts below: SEC While the first two business lines have proven themselves operationally, the notion of data centers in Earth orbit has not yet been proven. SpaceX has recorded $81.1 billion in fair market value investment from investors, including Mr. Musk and a large syndicate of corporate investors, venture capital firms, private equity firms, pension funds, private investors, and various sovereign wealth funds. What Are SpaceX’s Markets? SpaceX’s largest market by current revenue is the sa...

ALAB (NASDAQ) trusts sell shares via 10b5-1 plans, brokered by Morgan Stanley Stock Titan

First jobs? In this economy? On today’s Big Take podcast: How 2026 college graduates are adapting to a low-hire, low-fire environment. (Source: Bloomberg)

MDV Edwards/iStock via Getty Images Precigen, Inc.’s ( PGEN ) launch of Papzimeos in recurrent respiratory papillomatosis (RRP) continues. My last analysis was in March and followed the company's fourth-quarter earnings , in which management detailed interim Q1 revenue. Q1 was Papzimeos’ first full quarter on the market after its launch. Management expected revenues to “exceed $18 million,” which fell very close to the revenue bull band that I had proposed in November. I also performed a DCF model on Papzimeos and calculated that the asset is worth $1.8 billion in net present value, with a chance to generate around $800 million in peak annual sales. Given that Precigen’s market capitalization at that time was just $1.42 billion, I thought that Precigen’s stock looked undervalued, hence the Buy rating. PGEN is up just 9.5% since then, underperforming the S&P 500 ( SPY ) and its 15% returns during the same period. Data by YCharts Earlier this month, Precigen dropped its official Q1 report, projecting cash flow breakeven by the end of the year. While the headline numbers, like revenue, looked good, the lack of detail into relevant launch metrics leaves me scratching my head. Recent Developments Papzimeos ended up generating $21.6 million in net product revenue in the first quarter of 2026, which actually fell comfortably within my bull revenue band of greater than $20 million that I had proposed last November. I thought that such a result would support the view that Papzimeos is becoming the de facto standard of care in severe adult RRP. There are some signs that things will accelerate as the year progresses. For one, I see that Johns Hopkins Medicine and other major academic medical centers are administering Papzimeos for RRP. And as of April 1, 2026, Papzimeos was assigned a permanent J-code by the Centers for Medicare and Medicaid Services. Lastly, the fact that management is projecting cash flow breakeven by year-end would be a very impressive feat. Ordinarily, it ...

Image source: The Motley Fool. Monday, March 16, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Denis Phares Chief Revenue Officer — Wade Seaburg TAKEAWAYS Annual Net Sales -- $58.6 million, an increase of 16%, primarily from OEM channel growth. -- $58.6 million, an increase of 16%, primarily from OEM channel growth. OEM Revenue Growth -- 34% year over year, reflecting expanded integration with RV manufacturers and the trucking order from Werner Enterprises. -- 34% year over year, reflecting expanded integration with RV manufacturers and the trucking order from Werner Enterprises. Q4 Net Sales -- $13.1 million, up 6.9%, led by a 30% increase in OEM revenue. -- $13.1 million, up 6.9%, led by a 30% increase in OEM revenue. DTC Revenue -- Declined to $4.7 million from $5.7 million, attributed to continued market headwinds and strategic shift away from this channel. -- Declined to $4.7 million from $5.7 million, attributed to continued market headwinds and strategic shift away from this channel. Gross Profit and Margin (Q4) -- $2.4 million with an 18.2% margin, compared to $2.5 million and 20.8% margin previously; management cited the impact of restructuring costs on margins. -- $2.4 million with an 18.2% margin, compared to $2.5 million and 20.8% margin previously; management cited the impact of restructuring costs on margins. Annual Gross Margin -- Improved by 370 basis points to 26.7% with higher manufacturing utilization. -- Improved by 370 basis points to 26.7% with higher manufacturing utilization. Adjusted EBITDA (Q4) -- Negative $3.8 million, down from negative $2.3 million, while full year adjusted EBITDA improved to negative $11.4 million from negative $18.5 million. -- Negative $3.8 million, down from negative $2.3 million, while full year adjusted EBITDA improved to negative $11.4 million from negative $18.5 million. Net Loss (Q4) -- $45 million, compared to $9.8 million, driven by one-time restructuring expenses; net loss per share was $14...

Miller Value Partners initiated a new position in Crescent Energy (CRGY 3.06%) in its May 15, 2026, SEC filing, acquiring 2,003,132 shares for an estimated $20.98 million based on quarterly average pricing. What happened According to a SEC filing dated May 15, 2026, Miller Value Partners disclosed a new position in Crescent Energy, acquiring 2,003,132 shares. The estimated transaction value was approximately $20.98 million, based on the average closing price during the first quarter of 2026. The quarter-end value of the position rose to $27.04 million, reflecting both the share acquisition and changes in CRGY’s stock price through March 31, 2026. What else to know This was a new position, representing 7.06% of Miller Value Partners’ 13F reportable assets under management as of March 31, 2026 Top holdings after the filing: NYSE: NBR: $38.25 million (10.0% of AUM) NYSE: GTN: $23.31 million (6.1% of AUM) NYSE: LNC: $20.26 million (5.3% of AUM) NYSEMKT: SPY: $19.54 million (5.1% of AUM) As of Thursday, Crescent Energy shares were priced at $13.10, up about 50% over the past year and well outperforming the S&P 500, which is instead up about 27%. Company Overview Metric Value Revenue (TTM) $3.8 billion Net Income (TTM) ($284.79 million) Dividend Yield 3.78% Company Snapshot Crescent Energy produces and sells crude oil, natural gas, and natural gas liquids from a diversified portfolio of U.S. basins, including Eagle Ford, Rockies, Barnett, Permian, and Mid-Continent. The firm operates an upstream exploration and production business model, generating revenue primarily from the extraction and sale of hydrocarbons. It is headquartered in Houston, Texas, with a focus on operational scale and efficiency across multiple basins. Crescent Energy is a Houston-based independent energy producer with a multi-basin portfolio and a focus on operational scale and efficiency. The company leverages a deep inventory of drilling locations and proven reserves to drive production and cash flow...

Current ratio of Meta Platforms Inc Class A – BVL:METAUS TradingView

Micron Technology Options Spot-On: On May 21st, 675.39K Contracts Were Traded, With 3.27 Million Open Interest 富途牛牛